Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Challenges of maintaining accountability in networks of health and care organisations: A study of developing Sustainability and Transformation Partnerships in the English National Health Service.
Moran, V; ALLEN, P; SANDERSON, M; McDermott, I; OSIPOVIC, D;
2020
Social Science and Medicine, (2020).268, 10.1016/j.socscimed.2020.113512.
Unpacking the implementation blackbox using 'actor interface analysis': how did actor relations and practices of power influence delivery of a free entitlement health policy in India?.
Parashar, R; Gawde, N; Gupt, A; GILSON, L;
2020
Health Policy and Planning, (2020).35 Supple 10.1093/heapol/czaa125.
Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with Metformin.
Wehler, E; Lautsch, D; Kowal, S; Davies, G; BRIGGS, A; Li, Q; Rajpathak, S; Alsumali, A;
2020
PHARMACOECONOMICS, (2020).39 3 10.1007/s40273-020-00967-7.
First-line support for assistance in breathing in children: statistical and health economic analysis plan for the FIRST-ABC trial.
Orzechowska, I; Sadique, MZ; Thomas, K; Davis, P; Morris, KP; Mouncey, PR; Peters, MJ; Richards-Belle, A; Tume, LN; Ramnarayan, P; Harrison, DA;
2020
Trials, (2020).21 1 10.1186/s13063-020-04818-w.
Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled data.
FERNANDES, S; Were, V; Gutman, J; Dorsey, G; Kakuru, A; Desai, M; Kariuki, S; Kamya, MR; Ter Kuile, FO; HANSON, K;
2020
The Lancet. Global health, (2020).8 12 10.1016/S2214-109X(20)30369-7.
Participatory learning and action cycles with women's groups to prevent neonatal death in low-resource settings: A multi-country comparison of cost-effectiveness and affordability.
Pulkki-Brännström, A-M; Haghparast-Bidgoli, H; Batura, N; Colbourn, T; Azad, K; Banda, F; Banda, L; BORGHI, J; Fottrell, E; Kim, S; Makwenda, C; Ojha, AK; Prost, A; Rosato, M; Shaha, SK; Sinha, R; Costello, A; Skordis, J;
2020
Health Policy and Planning, (2020).35 10 10.1093/heapol/czaa081.
Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries.
Ochalek, J; ABBAS, K; Claxton, K; JIT, M; Lomas, J;
2020
BMJ global health, (2020).5 10 10.1136/bmjgh-2020-003006.
The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on rifampicin resistant and multidrug resistant tuberculosis in India and China.
WEERASURIYA, C; Harris, R; MCQUAID, C; BOZZANI, F; Gomez, GB; WHITE, R;
2020
(2020).
Estimating the economic burden of post-tuberculosis: data gaps and research priorities.
SWEENEY, S;
2020
(2020).
Informing Global Cost-Effectiveness Thresholds Using Country Investment Decisions: Human Papillomavirus Vaccine Introductions in 2006-2018.
JIT, M;
2020
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, (2020).24 1 10.1016/j.jval.2020.07.012.